ghk-cu peptide injection research GHK-Cu for Skin Rejuvenation -

Failure to comply with the DPA and its obligations, including the breach of duties of disclosure or due diligence, can result in a fine of up to CHF 250,000 for the controller

Gastrointestinal adverse events, including nausea, constipation, diarrhea, and vomiting, are the most commonly reported side effects

1 Most people experience no side effects

In particular, the peptide is believed to support the recovery of the gastric lining by encouraging the regeneration of cells essential for maintaining mucosal integrity

Mojca Jensterle has received lecture honoraria from Novo Nordisk, Eli Lilly, Pfizer, Amgen, Novartis and Sanofi, and is an advisory board member of Novo Nordisk, Eli Lilly, Amgen and Pfizer